SEC Filings

Filing date	Form	Description	View
05/03/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-006193.pdf 0001179110-18-006193.rtf 0001179110-18-006193.xls
05/03/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-006195.pdf 0001179110-18-006195.rtf 0001179110-18-006195.xls
05/03/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-006196.pdf 0001179110-18-006196.rtf 0001179110-18-006196.xls
05/03/18	4	Statement of changes in beneficial ownership of securities	View HTML 0001179110-18-006197.pdf 0001179110-18-006197.rtf 0001179110-18-006197.xls
05/02/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-029882.pdf 0001104659-18-029882.rtf 0001104659-18-029882.xls
05/01/18	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-18-029378.pdf 0001104659-18-029378.rtf 0001104659-18-029378.xls
04/19/18	CT ORDER	CT ORDER	View HTML 9999999997-18-005009.pdf
03/21/18	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	View HTML Theravance Biopharma, Inc. Proxy Statement.pdf 315.4 KB 0001047469-18-001961.rtf 0001047469-18-001961.xls
03/06/18	S-8	Securities offered to employees pursuant to employee benefit plans	View HTML 0001104659-18-015270.pdf 0001104659-18-015270.rtf 0001104659-18-015270.xls
02/28/18	10-K	Annual report which provides a comprehensive overview of the company for the past year	View HTML Theravance Biopharma, Inc. Annual Report.pdf 359 KB 0001047469-18-001160.rtf 0001047469-18-001160.xls EX-101.INS - EX-101.INS

Data provided by Kaleidoscope.

For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.